VP, Program and Portfolio Management

Paul T. Yarabe is our VP of Program and Portfolio Management. He has experience in program management, budget planning, CMC supply chain, regulatory/clinical operations, clinical development, and grant writing. Prior to joining Leal, he served as the global program manager for Rocket Pharmaceutical’s Danon Disease AAV gene therapy asset, helping to advance the program from preclinical to a registrational Phase 2. He holds a B.A. in Molecular and Cellular Biology from Harvard College, and an MBA from Harvard Business School.